Doubling Research Means Doubling Education

It is encouraging that a bipartisan congressional leadership has called for a doubling of the current level of federal investment in research within the next 10 years. And the Clinton administration's budget submission is a clear indication that the other end of Pennsylvania Avenue heard the call. But with this call and reponse comes a major responsibility to make a credible argument for such enhancement, and we scientists and engineers must do our part to make that case. True, even the call a

Written byEarl Dowell
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

It is encouraging that a bipartisan congressional leadership has called for a doubling of the current level of federal investment in research within the next 10 years. And the Clinton administration's budget submission is a clear indication that the other end of Pennsylvania Avenue heard the call. But with this call and reponse comes a major responsibility to make a credible argument for such enhancement, and we scientists and engineers must do our part to make that case.

True, even the call and response themselves are hopeful signs, given that until recently the government debate was over the size of projected cuts in federal research spending. Focusing on the size of a possible increase is certainly a more healthy debate for the country and for those responsible for investing wisely in our future.

However, it is still largely unclear which societal needs will prove most persuasive to Congress and the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies